Table 1.
ID | Sex | Fazekas Total* | Lesion volume (cm3) | Stroke Age | Age Test 1 | Age Test 2 | Education (y) | Test Interval (m) | AQ** Initial | AQ Follow- up | Aphasia Type | Improve/ Decline*** |
---|---|---|---|---|---|---|---|---|---|---|---|---|
M2002 | M | 1 | 152.60 | 55 | 59 | 65 | 16 | 85 | 68.1 | 72.6 | Broca’s | Improve |
M2005 | F | 3 | 59.08 | 31 | 38 | 43 | 16 | 62 | 55.2 | 54.8 | Broca’s | Stable |
M2006 | M | 4 | 96.79 | 47 | 58 | 61 | 10 | 42 | 90.2 | 85.8 | Anomia | Decline |
M2014 | M | 0 | 70.78 | 56 | 57 | 62 | 12 | 55 | 88.8 | 94.0 | Anomia | Improve |
M2016 | M | 4 | 365.41 | 55 | 62 | 69 | 22 | 87 | 50.7 | 30.9 | Broca’s | Decline |
M2025 | M | 2 | 155.72 | 50 | 53 | 56 | 16 | 38 | 70.7 | 64.6 | Broca’s | Decline |
M2029 | M | 0 | 195.39 | 43 | 43 | 50 | 16 | 83 | 25.7 | 40.6 | Broca’s | Improve |
M2030 | M | 1 | 202.00 | 54 | 58 | 65 | 16 | 78 | 47.6 | 51.5 | Broca’s | Improve |
M2031 | M | 2 | 148.87 | 56 | 57 | 60 | 20 | 44 | 31.2 | 34.4 | Conduction | Improve |
M2036 | M | 2 | 147.89 | 50 | 52 | 58 | 18 | 67 | 72.7 | 72.2 | Broca’s | Stable |
M2039 | F | 2 | 12.56 | 39 | 42 | 45 | 15 | 30 | 87.6 | 88.6 | Anomia | Stable |
M2040 | M | 2 | 240.06 | 49 | 49 | 55 | 16 | 73 | 32.7 | 48.7 | Broca’s | Improve |
M2042 | M | 2 | 202.14 | 60 | 66 | 67 | 12 | 24 | 73.5 | 61.6 | Broca’s | Decline |
M2044 | F | 4 | 146.18 | 44 | 50 | 53 | 13 | 32 | 73.5 | 74.8 | Broca’s | Stable |
M2046 | F | 3 | 194.92 | 49 | 54 | 56 | 14 | 22 | 49.3 | 55.9 | Conduction | Improve |
M2049 | F | 3 | 9.28 | 67 | 70 | 74 | 16 | 56 | 46.9 | 63.4 | Conduction | Improve |
M2061 | M | 1 | 97.03 | 63 | 64 | 65 | 15 | 7 | 46.3 | 52.7 | Wernicke’s | Improve |
M2086 | M | 2 | 118.35 | 71 | 72 | 76 | 20 | 50 | 73.5 | 60.5 | Conduction | Decline |
M2087 | M | 3 | 234.61 | 52 | 69 | 71 | 16 | 31 | 55.3 | 45.9 | Broca’s | Decline |
M2102 | M | 1 | 63.56 | 47 | 47 | 51 | 12 | 39 | 73.8 | 86.0 | Conduction | Improve |
M2109 | F | 6 | 109.69 | 66 | 67 | 69 | 12 | 26 | 47.8 | 39.8 | Conduction | Decline |
M2115 | M | 2 | 210.30 | 64 | 64 | 66 | 16 | 21 | 38.9 | 36.3 | Broca’s | Stable |
M2118 | M | 2 | 130.76 | 54 | 55 | 56 | 18 | 10 | 37.6 | 41.0 | Broca’s | Improve |
M2127 | M | 2 | 220.17 | 58 | 59 | 60 | 12 | 7 | 57.8 | 52.1 | Broca’s | Decline |
M2136 | F | 3 | 113.30 | 67 | 69 | 70 | 12 | 7 | 38.7 | 28.6 | Broca’s | Decline |
M2165 | M | 3 | 340.18 | 52 | 53 | 55 | 16 | 25 | 5.6 | 20.1 | Broca’s | Improve |
M2172 | M | 2 | 65.02 | 68 | 69 | 69 | 18 | 9 | 75.9 | 77.2 | Anomia | Stable |
M2173 | M | 3 | 92.17 | 71 | 72 | 73 | 12 | 10 | 62.2 | 57.8 | Broca’s | Decline |
M2176 | M | 2 | 114.42 | 66 | 68 | 69 | 13 | 9 | 72.7 | 68.9 | Conduction | Decline |
M4138 | M | 1 | 52.12 | 62 | 66 | 67 | 14 | 10 | 77.8 | 90.4 | Anomia | Improve |
M4141 | F | 2 | 24.02 | 43 | 50 | 54 | 12 | 51 | 80.8 | 79.2 | Broca’s | Stable |
M4148 | M | 1 | 177.67 | 49 | 49 | 50 | 10 | 7 | 20.1 | 26.0 | Broca’s | Improve |
M4214 | M | 2 | 96.88 | 69 | 70 | 71 | 15 | 6 | 41.9 | 46.6 | Wernicke’s | Improve |
M4217 | M | 2 | 193.61 | 68 | 70 | 71 | 16 | 6 | 47.3 | 66.8 | Broca’s | Improve |
M4223 | F | 1 | 213.37 | 48 | 50 | 50 | 18 | 10 | 30.1 | 39.0 | Broca’s | Improve |
Mean | -- | 2.20 | 144.77 | 55.5 | 58.6 | 61.5 | 15 | 34.8 | 55.7 | 57.4 | -- | -- |
SD | -- | 1.13 | 82.69 | 10 | 9.5 | 8.8 | 2.9 | 26.2 | 21.1 | 19.9 | -- | -- |
Abbreviations: AQ: aphasia quotient; m: months; y: years. Note lesion volume is reported in cm3.
A score from 0 (no presence of leukoaraiosis) to 6 (severe confluent leukoaraiosis in both periventricular and deep white matter spaces).
AQ, aphasia quotient, derived from the Western Aphasia Battery.24 A score of <93.8 indicates presence of aphasia; lower scores are consistent with more severe aphasia.
Improvement, decline, and stability defined by a three-point change in AQ, where change ≥3 was considered improvement, change ≤ 3 was considered a decline, and a less than three-point change in either direction was considered “stable.”3